Net Loss per Share

9 Months Ended

Sep. 30, 2019

5. Net Loss per Share

Basic net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding for the period. The Company’s potentially dilutive shares, which include outstanding common stock options, unvested restricted stock and preferred stock, have not been included in the computation of diluted net loss per share for any of the periods presented as the result would be anti-dilutive. Such potentially dilutive shares of common stock at September 30, 2019 and 2018 consisted of the following:


	September 30,
	2019		2018
Stock options		4,995,549		4,569,468
Inducement stock options		965,000		—
Unvested restricted stock		1,569,579		1,164,352
Warrants		18,939,394		—
Preferred stock		—		52,583,921

		26,469,522		58,317,741

On October 5, 2018, the Company and Precigen, Inc., or Precigen, a wholly owned subsidiary of Intrexon Corporation, or Intrexon, entered into an exclusive license agreement, or the License Agreement, to replace all existing agreements between the companies that provides the Company with certain exclusive and

non-exclusive

rights to technology controlled by Precigen. In consideration of the Company entering into the License Agreement, Intrexon agreed to forfeit and return to the Company all shares of the Company’s Series 1 Preferred Stock held by or payable to Intrexon as of the date of the License Agreement (Note

)